We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CAPR market cap is 629.63M. The company's latest EPS is USD -0.6850 and P/E is -28.41.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.92M | 6.19M | 12.09M | 4.91M | 3.97M |
| Operating Income | -7.75M | -8.57M | -1.28M | -10.27M | -11.59M |
| Net Income | -7.37M | -6.39M | -763k | -9.79M | -11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.01M | 310k | 245k | 2.55M | 25.18M |
| Operating Income | -7.73M | -13.69M | -20.94M | -29.7M | -24.08M |
| Net Income | -7.64M | -13.66M | -20.02M | -29.02M | -22.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.01M | 37.15M | 58.73M | 49.44M | 38.28M |
| Total Liabilities | 43.28M | 38.94M | 36.13M | 31.01M | 26.78M |
| Total Equity | 2.73M | -1.79M | 22.6M | 18.44M | 11.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.11M | 34.62M | 41.33M | 50.1M | 58.73M |
| Total Liabilities | 4.28M | 6.42M | 9.96M | 38.31M | 36.13M |
| Total Equity | 6.84M | 28.2M | 31.37M | 11.79M | 22.6M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.21M | -14M | -25.6M | -1.27M | -13.56M |
| Investing | 3.25M | 10.97M | 5.11M | -9.5M | 5.19M |
| Financing | 2.19M | 2.41M | 25.58M | 2.29M | 4.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.82M | -10.05M | -16.81M | 4.92M | -25.6M |
| Investing | -3M | 5.44M | -1.2M | -35.07M | 5.11M |
| Financing | 9.18M | 33.38M | 20.23M | 4.87M | 25.58M |
| Market Cap | 629.63M |
| Price to Earnings Ratio | -28.41 |
| Price to Sales Ratio | 25.15 |
| Price to Cash Ratio | 43.09 |
| Price to Book Ratio | 28.02 |
| Dividend Yield | - |
| Shares Outstanding | 32.54M |
| Average Volume (1 week) | 1.16M |
| Average Volume (1 Month) | 2.99M |
| 52 Week Change | 586.17% |
| 52 Week High | 23.40 |
| 52 Week Low | 2.68 |
| Spread (Intraday) | 0.46 (2.32%) |
| Company Name | Capricor Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.capricor.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
